Biotech unicorn Moderna raises another $125M from partner Merck By: Boston Business Journal via Business Journals May 03, 2018 at 17:48 PM EDT The privately held Cambridge biotech is valued at $7 billion, making it a rare unicorn in the Massachusetts life sciences industry. Read More >>